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Reducing GABAA-mediated 
inhibition improves forelimb motor 
function after focal cortical stroke 
in mice
Claudia Alia1,2, Cristina Spalletti2, Stefano Lai3, Alessandro Panarese3, Silvestro Micera3,4 & 
Matteo Caleo2
A deeper understanding of post-stroke plasticity is critical to devise more effective pharmacological and 
rehabilitative treatments. The GABAergic system is one of the key modulators of neuronal plasticity, 
and plays an important role in the control of “critical periods” during brain development. Here, we 
report a key role for GABAergic inhibition in functional restoration following ischemia in the adult 
mouse forelimb motor cortex. After stroke, the majority of cortical sites in peri-infarct areas evoked 
simultaneous movements of forelimb, hindlimb and tail, consistent with a loss of inhibitory signalling. 
Accordingly, we found a delayed decrease in several GABAergic markers that accompanied cortical 
reorganization. To test whether reductions in GABAergic signalling were causally involved in motor 
improvements, we treated animals during an early post-stroke period with a benzodiazepine inverse 
agonist, which impairs GABAA receptor function. We found that hampering GABAA signalling led to 
significant restoration of function in general motor tests (i.e., gridwalk and pellet reaching tasks), with 
no significant impact on the kinematics of reaching movements. Improvements were persistent as 
they remained detectable about three weeks after treatment. These data demonstrate a key role for 
GABAergic inhibition in limiting motor improvements after cortical stroke.
Recovery of arm function is a high priority for individuals with motor cortex injuries. Following cortical stroke, 
some spontaneous motor improvements occur within the first months after the insult, but the underlying mech-
anisms are only partly understood1–4.
Rodent models can provide detailed insights into the mechanisms responsible for spontaneous and 
rehabilitation-induced motor improvements. A variety of motor tests have been developed for these species5–7, 
and, in particular, skilled reaching in rodents shares many similarities with the homologous behavior in humans8.
Following an ischemic lesion, a substantial reorganization of both neural and glial/endothelial cells takes 
place in the injured area4,9. In animal models, reorganization of motor maps has been observed10–12 showing 
a post-stroke shrinkage of the paretic limb map, prevented by an early rehabilitation, which is also effective at 
improving motor function13–15.
Little is known about the cellular mechanisms that lead to these network reorganizations and recovery of the 
lost motor function. The GABAergic system and the extracellular matrix could have an important role in con-
trolling plastic phenomena16. For example, Perineuronal Nets (PNNs), preferentially surrounding the soma of 
fast-spiking parvalbumin-positive interneurons17, and the GABAergic system have been extensively investigated 
during the maturation and plasticity of the visual system18–20. Moreover, following CNS injury, the degradation 
of PNNs promotes sensory-motor recovery21–23. Increasing GABAergic signalling after stroke is not effective at 
improving motor performances16, but rather produces a worsening of recovered function in stroke patients24. 
Conversely, a reduced GABAergic inhibition is associated with functional recovery25–27.
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Ionotropic GABAA receptors mainly mediate the inhibitory effect of GABA in the brain28,29. GABAA recep-
tors are composed of different subunits and the resulting molecular assembly determines the localization and 
biological action of the receptor. A general downregulation of GABAA receptors has been found in peri-infarct 
areas following photothrombosis-induced lesions in rats and mice30–32. Moreover, an experimental reduction 
of post-stroke, excessive tonic GABA signalling produces significant post-stroke improvements of forelimb 
function5,33.
Here we have investigated how the restoration of lost motor function in mice is related to modulation of 
inhibitory GABAergic signalling following a targeted photothrombotic lesion to the forelimb primary motor area 
(Caudal Forelimb Area, CFA). We found that network reorganization after stroke was associated with a delayed 
reduction of “plasticity brakes” including PNNs and GABAergic markers. Thus, we targeted GABAergic signal-
ling in an early post-stroke period, using methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM), 
an inverse benzodiazepine agonist that inhibits GABA currents34 by binding to the α subunits of the GABAA 
receptor (affinity: α 1 > α 2 = α 3 > α 5)35–37. Specifically, DMCM acts by decreasing the affinity of the receptors 
for released GABA38 thus allowing the modulation of endogenous intracortical inhibition during post-stroke 
plasticity. Using sensitive behavioural readouts such as the gridwalk and pellet reaching tasks, we demonstrate 
that DMCM treatment caused significant and long-lasting motor improvements, with no significant impact on 
the kinematics of reaching movements.
Results
Deficits in forelimb function following stroke. We induced a focal injury in the caudal forelimb area 
(CFA) of the mouse motor cortex using Rose Bengal-mediated photothrombosis39. The ischemic lesion was con-
fined to the targeted cortical area of the illuminated hemisphere. The histopathological analysis was conducted 
30 days after the ischemic injury and showed that the lesion volume was 0.93 ± 0.21 mm3. Our typical lesion 
remained confined into the CFA and did not involve the Rostral Forelimb Area (between + 1.5 and + 2.25 mm 
anterior to bregma suture) and the hindlimb representation (between − 0.75 and − 1.25 mm posterior to bregma) 
according to average maps published in the literature12 (see also below). Coronal section of the ischemic brains 
demonstrated a complete loss of neurons in the core of the infarct, and well-defined boundaries that separate the 
lesion from the healthy perilesional tissue (Supplementary Fig. S1a).
To investigate the time-course of functional motor deficits, animals were tested on two motor tasks (grid-
walk, Schallert cylinder) before the injury (baseline) and up to 30 days after the ischemic lesion (once a week 
starting from day 2). Supplementary Fig. S1b reports the percentage of foot faults done with the contralesional 
forelimb in the gridwalk test. After the ischemic injury, stroke mice (n = 11) showed a significant and stable 
increase in forelimb foot faults as compared to sham-treated animals (n = 9). Conversely no changes in foot 
faults were observed for the contralesional hindlimb, confirming the anatomical specificity of the stroke location 
(Supplementary Fig. S1c). The Asymmetry Index evaluated with the Schallert cylinder test showed increased reli-
ance on the ipsilesional forelimb during exploration of the vertical walls in ischemic mice throughout the testing 
period (Supplementary Fig. S1d). Proficiency in other motor tests appears to improve spontaneously after injury, 
especially when end-point measures are used. Indeed, it has been clearly shown that sensory-motor performances 
(including reaching success in the pellet grasping task) improve already after 2 weeks39–43.
Plastic modifications of motor maps after injury. Intracortical microstimulation (ICMS) was used to 
investigate the spontaneous remapping of motor areas, 30 days after the ischemic lesion. Specifically, we measured 
the extension and selectivity of the cortical representation of the affected forelimb in the intact areas surrounding 
the infarct.
Forelimb motor maps from sham (n = 9) and stroke (n = 6) animals are compared in Fig. 1a–c. In control ani-
mals, the CFA is well defined and extends from approximately − 1.0 mm posterior up to 1.25 mm anterior to the 
bregma suture, consistent with previous reports44. A second, smaller forelimb representation (Rostral Forelimb 
Area, RFA) is centred at about 2.5 mm anterior to bregma (Fig. 1a). This area displays a slightly higher current 
threshold for evoking limb movements as compared to the CFA (RFA, 36.5 ± 10.9 μ A; CFA, 28.9 ± 5.7 μ A; t-test, 
p = 0.08). After injury, the area corresponding to the infarct (shaded region in Fig. 1a,b) was no longer effec-
tive in triggering forelimb movements. Areas anterior and posterior to the lesion continued to evoke a forelimb 
response after stroke (Fig. 1b). However, the quantitative analysis, performed only in the healthy tissue (included 
between − 0.75 mm and − 2 mm and between + 1.5 mm and + 2.75 mm anteroposterior to bregma) indicated a 
significant shrinkage of the forelimb area in perilesional cortex of ischemic animals as compared to the corre-
sponding regions in controls. In fact, the percentage of responding area in peri-infarct cortex indicated a reduced 
representation of the contralesional forelimb in ischemic mice (t-test, p = 0.03) (Fig. 1c). The effect was evident 
and significant across a range of stimulation intensities (20–40 μ A; data not shown). It is also worth noting that 
the current threshold required for eliciting a forelimb movement in perilesional areas significantly increased after 
stroke (Supplementary Fig. S2a; t-test, p = 0.003). In normal animals, we also observed ipsilateral forelimb move-
ments (percentage of responsive area was 26.9 ± 4.1). After stroke, there are not significant changes of the exten-
sion of the ipsilateral forelimb area in the spared motor cortex anterior and posterior to the lesion (23.0 ± 7.5; 
t-test, p = 0.63).
During ICMS, we also examined movements of other body parts such as the hindlimbs and tail. In normal 
animals, the contralateral hindlimb and tail representations are smaller than the forelimb and occupy the cau-
dal extent of primary motor cortex12. Interestingly, we found that the proportion of sites mapping the contral-
esional hindlimb increased in the perilesional cortex of ischemic mice, thus invading forelimb representation 
(t-test, p = 0.04) (Fig. 1d–f). There was also a non-significant trend towards a post-stroke reduction in the current 
threshold required for eliciting hindlimb movements in forelimb area (Supplementary Fig. S2b; t-test, p = 0.148). 
Expansion of the hindlimb map was evident and significant at various stimulation currents (20–60 μ A). 
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In contrast, the overall dimensions of the tail map did not change significantly in stroke vs. control mice 
(t-test, p = 0.551) (Fig. 1g–i). During stimulation, we observed very sporadic ipsilateral hindlimb movements 
Figure 1. Plasticity of motor maps after stroke. Average motor maps of sham (n = 9) and ischemic animals 
(n = 6) obtained by the intracortical microstimulation (ICMS) technique following a grid of stimulation 
site of 250 μ m (see coordinates from bregma and Fig. 2a). For each pixel in the maps, a color code indicates 
the probability (high – red; low – blue) to elicit movement of a body part (contralateral forelimb in (a,b); 
contralateral hindlimb in (d,e); tail in (g,h) after stimulation with a train of cathodal pulses (current, 30 μA). 
The quantitative analysis was performed in healthy regions rostral and caudal to the stroke, excluding the 
infarct zone, which is indicated by the shaded areas (black dots indicate the center of the lesion). (c,f,i) 
Quantification of the percentage of perilesional motor areas eliciting forelimb (c), hindlimb (f) and tail 
responses (i) in sham and stroke animals. After stroke, there is a significant decrease in the cortical area that 
evokes forelimb responses (t-test, p < 0.05), with a corresponding expansion of hindlimb motor maps  
(t-test, p < 0.05). Tail representations are not altered by the infarct (t-test, p = 0.551). Data are mean ± SE.
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(percentage of responding area 2.5 ± 2.4). After stroke the area eliciting a ipsilateral hindlimb movement was 
increased (11.2 ± 4.9) but this trend did not reach statistical significance (t-test, p = 0.1).
Overall, these data indicate a significant reduction of the size of forelimb representations in the intact perile-
sional tissue, with corresponding expansion and invasion of hindlimb maps. We next investigated whether the 
functional selectivity of the perilesional tissue was affected in stroke vs. control animals. Selectivity was quantified 
by counting the proportion of cortical sites evoking movement of 1, 2 or 3 parts of the body (i.e., contralesional 
forelimb, contralesional hindlimb and tail) using a 30 μ A stimulation current. We found that the majority of sites 
in normal animals evoke the movement of either 1 or 2 body parts, whereas very few sites evoke simultaneous 
movements of forelimb, hindlimb, and tail (Fig. 2a,b). The picture was radically different in ischemic animals, 
where very few sites were specific for the forelimb (t-test, p = 0.011), and the majority of cortical locations drove 
movements of 2 or 3 body parts, even at low current intensities (t-test, p = 0.046; Fig. 2b).
We also investigated whether specific locations in the perilesional cortex consistently lose or gain forelimb 
preference following a cortical infarct. To this aim, we computed a “Transition Index” (TI) (see Methods) that 
indicates with a colorimetric scale if each cortical site gains (blue) or loses (red) forelimb movements after stroke 
(Fig. 2c). Overall, a robust loss of forelimb sites was evident both anterior and posterior to the infarct, with the 
exception of a postero-medial area (blue) that appears to gain forelimb responses in stroke vs. sham mice (Fig. 2c).
Downregulation of GABAergic markers following stroke. We next used immunostaining to evaluate 
expression of markers of plasticity18,45 in perilesional cortical areas. We performed staining for perineuronal 
nets (PNNs), somatostatin and parvalbumin-positive (SOM- and PV-positive) inhibitory interneurons, and glu-
tamatergic and GABAergic terminals. Three groups of animals were examined: a sham group with no injury 
(n = 6), and ischemic animals at either 7 (n = 8) or 30 days post-lesion (n = 8). The analysis was performed in 
cortical areas adjacent to the infarct as illustrated in Supplementary Fig. S3. To ensure consistency among animals 
and lesions, we sampled well defined areas in the perilesional region. Specifically, the density of PNNs, PV- and 
SOM-positive cells was determined in cortical columns (200 μ m wide) medial and lateral to the lesion, while 
glutamatergic and GABAergic synaptic terminals were sampled in counting boxes located in both superficial and 
deep layers of peri-infarct cortex (Supplementary Fig. S3). Homotopic regions of the contralesional hemisphere 
were examined as well, but we did not detect any significant changes in ischemic animals with respect to sham 
controls (data not shown).
The density of PNNs was assessed by staining cortical sections with Wisteria Floribunda Agglutinin (WFA). 
PNNs enwrap specific sub-populations of neurons and are known to play a key role in limiting adult plas-
ticity18,22,23. We found that the density of PNNs remained unaltered at day 7 but consistently decreased 30 days 
after stroke in cortical columns medial and lateral to the infarct (one way ANOVA followed by Holm-Sidak 
test, medial and lateral, p < 0.001; Fig. 3). Since PNNs mainly surround PV-positive cells (corresponding mainly 
to fast-spiking inhibitory neurons), we then measured the density of this neural population. PV-positive cells 
showed the same trend as PNNs, and were significantly downregulated 30 but not 7 days after stroke (one way 
ANOVA, followed by Holm-Sidak medial p = 0.027; lateral p = 0.009; Fig. 4a). Another important class of inhib-
itory interneurons, namely SOM-positive cells, also showed a consistent downregulation following injury. In this 
case, a statistically significant decrease in cell density was already noted at day 7 (one way ANOVA, followed by 
Holm-Sidak test, medial p = 0.023; lateral p = 0.017), and further progressed at day 30 (medial p = 0.001, lateral 
p = 0.003; Fig. 4b).
To study more precisely the excitation/inhibition ratio in perilesional cortex, we stained sections for vesic-
ular transporter markers that label inhibitory and excitatory terminals impinging onto cortical neurons46,47. 
Quantitative analysis of the immunostaining for the Vesicular GABA Transporter (V-GAT) indicated that 
the overall fluorescence of inhibitory terminals was unaffected at day 7, but robustly declined at day 30. This 
reduction was noted in superficial and deep layers on both sides of the infarct (one way ANOVA, followed by 
Holm-Sidak test, p < 0.01 for all comparisons; Fig. 5a,c). We also quantified perisomatic staining by measuring 
the mean V-GAT fluorescence in “puncta rings” surrounding cortical neurons18,48. We detected a decrease of flu-
orescence 30 days after stroke that was significant in superficial layers (one way ANOVA, followed by Holm-Sidak 
test, medial p < 0.01; lateral p < 0.05; Fig. 5b,c).
To evaluate excitatory terminals, we quantified immunostaining for the Vesicular Glutamate Transporter 1 
(V-GluT1) in lateral and medial perilesional cortex. We found no significant changes in the mean V-GluT1 fluo-
rescence in the neuropil either at 7 or 30 days after stroke (one way ANOVA, p > 0.52 for all peri-infarct regions; 
Fig. 6a–c). Similarly, the intensity of perisomatic excitatory boutons showed no significant variation after stroke 
(p > 0.63; Fig. 6b,c).
Overall, these data show a consistent downregulation of PNNs and several inhibitory markers in the 
peri-infarct cortex 30 days after stroke. Conversely, we found no detectable variation in V-GluT1 expression, 
indicating an overall shift of the excitation/inhibition ratio in favour of excitation. Increases in the excitation/
inhibition balance are typically associated with an enhanced potential for plasticity in the adult cortex20,49,50, indi-
cating their possible involvement in the spontaneous functional improvements occurring within the first weeks 
after stroke39–43.
Interference with GABAA signalling promotes functional restoration. The post-stroke reduction of 
GABAergic markers prompted us to investigate the role of GABA signalling in motor improvements. We decided 
to hamper GABAA mediated neurotransmission during an early phase post-lesion (days 3–8) via systemic deliv-
ery of the benzodiazepine inverse agonist DMCM. We initially established doses of DMCM (1.5 mg/kg) that were 
well below those required to elicit epileptic seizures51–53, while at the same time impacting on GABA-mediated 
transmission as judged by a reduced path length in the open field52 (Supplementary Fig. S4).
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Figure 2. Loss of movement selectivity following a cortical infarct. (a) Scheme of the average map showing 
major changes in forelimb (FL), hindlimb (HL) and tail (TL) representation after stroke. Colors shows the 
preferential activation of different regions, showing the specificity of each zone (single vs multiple movements). 
Dotted circle indicates the average position of our ischemic lesion and white dots represent the grid of 
stimulation used in ICMS experiments. (b) Surface area eliciting movement of forelimb (FL) alone, 
forelimb + hindlimb (HL) or tail (TL), or the three body parts together at a stimulation current of 30 μ A in sham 
(black, n = 9) and ischemic animals (red, n = 6). The quantitative analysis was performed in regions rostral and 
caudal to the infarct (see Fig. 1). Following stroke, very few sites retain their selectivity for forelimb movements, 
while most cortical locations elicit simultaneous movement of forelimb, hindlimb and tail (t-test, p < 0.05). Data 
are mean ± SE. (c) Map of the Transition Index (TI; see Methods) showing for each pixel the tendency to gain 
(blue) or lose (red) forelimb movement after stroke in our experimental sample. The colorimetric index is 
defined within a range of ± 2 (see Methods).
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Mice were treated with either DMCM (n = 10) or vehicle (n = 3) starting from day 3 after stroke and following 
assessment of the initial deficit in the gridwalk task (Fig. 7a). Injections were made daily until day 8 and motor 
function was again assessed at day 9 (i.e. immediately after treatment) and 30 (to probe persistence of the ther-
apeutic effect). As expected, vehicle-treated mice showed no improvements in motor function. Importantly, a 
reduction in the number of foot faults was evident for DMCM-treated animals at day 9 and persisted at day 30 
(two way RM ANOVA followed by Tukey test, day 9, p = 0.039; day 30, p = 0.038; Fig. 7a). We also assessed the 
impact of DMCM treatment on skilled reaching39 (DMCM n = 3; veh n = 3). The percentage of incorrect move-
ments decreased at day 9 showing a trend for improvement in DMCM animals. This effect of DMCM became 
significant at day 30 (two way RM ANOVA followed by Tukey test, p = 0.007; Fig. 7b). Thus, performance in two 
motor tasks was consistently enhanced in the DMCM animals well beyond the completion of the treatment. This 
effect was not due to a difference in the initial deficit, since DMCM and vehicle groups had a comparable perfor-
mance 2 days post lesion (two way RM ANOVA p > 0.095). We also quantified the number of total attempts made 
during the tests (i.e. reaching attempts in the skilled reaching test and steps performed in the gridwalk test) and 
we found no significant differences with respect to vehicle controls at 30 days post lesion (total steps made in the 
gridwalk test: DMCM 619.7 ± 96.46; Veh 635 ± 19.22; t-test p = 0.932; total attempts in the skilled reaching test: 
DMCM 63.6 ± 6; Veh 56 ± 7; t-test p = 0.454).
In the subset of the animals employed for the pellet grasping task, we performed a kinematic analysis of 
reaching to address the issue of “true” recovery vs. compensation39. We found that DMCM treatment did not 
significantly improve trajectory kinematics, as they remained longer (ArcLen, Two way RM ANOVA, DMCM vs. 
vehicle, p = 0.244; Fig. 8a) and less smooth (i.e., with an increased number of trajectory adjustments; Two way 
RM ANOVA, DMCM vs. vehicle, p = 0.330; Fig. 8b) as compared to baseline, pre-stroke values. Overall, these 
Figure 3. Reduced density of PNNs in peri-infarct areas. (a) Number of cells surrounded by PNNs in 200 μm 
wide cortical columns, lateral (black bars) and medial (grey bars) to the ischemic lesion, 7 (n = 5) and 30 days 
post injury (n = 8). Similar cortical regions were also sampled in controls (n = 8). PNN density is significantly 
reduced at 30 but not 7 days after stroke (one Way ANOVA, post hoc Holm-Sidak test, ***p < 0.001). Data are 
mean ± SE. (b) Representative images acquired from coronal sections of the motor cortex from sham and stroke 
mice at 7 and 30 days. Column width = 200 μ m.
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data indicate that hampering GABAA signalling after stroke produces significant and long-lasting improvements 
in motor function, and compensatory adjustments appear to be required for task accomplishment.
Discussion
Understanding cellular mechanisms governing post-stroke cortical plasticity is critical to develop novel and more 
effective pharmacological therapies to improve outcome in stroke survivors. The data reported in this manu-
script indicate a substantial remodelling of GABAergic networks during post-stroke map reorganization of spared 
forelimb motor cortex in mice. Importantly, early experimental interference with GABAA signalling triggered 
long-lasting restoration of forelimb function following a focal cortical infarct.
We focused our analysis on peri-infarct regions since evidence in patients and animal models indicate that 
spared areas surrounding the lesion significantly contribute to functional recovery11,43,54,55. In ICMS experiments, 
we observed a reduction in the number of cortical sites that elicited movements of the lesioned forelimb 30 days 
after stroke. This was accompanied by a corresponding invasion of the hindlimb motor map, that in healthy ani-
mals is centred posterior to the CFA56,57. Our results are consistent with previous reports indicating shrinkage of 
the cortical representation of affected forelimb in favour of other body parts10,58. These motor map reorganiza-
tions are reminiscent of activity-dependent competition in sensory cortices18,59,60.
The current threshold to evoke movements also changed after stroke. Overall, a higher current intensity was 
required to evoke a forelimb movement post-stroke, while hindlimb movements were elicited with a slightly 
reduced current. In keeping with our results, previous studies in humans and rodents have shown an inverse cor-
relation between the current threshold and the size of the motor map61,62. Young and colleagues (2011) correlated 
GABAergic neurotransmission with cortical map properties, so that a shift in the balance between excitation and 
inhibition influenced both movement thresholds and map size. It has also been suggested that inhibitory neuro-
transmission is responsible for the stability and sharpening of motor and sensory maps13,63,64. Specifically, local 
reduction of intracortical inhibition allows the unmasking of subthreshold inputs and the consequent expansion 
of adjacent motor maps65. In this context, a reduction of GABAergic inhibition might allow plasticity of spared 
areas and pathways following stroke. Indeed, our neuroanatomical analyses revealed a significant reduction of two 
Figure 4. Reduced density of GABAergic interneurons in peri-infarct areas. (a,b) Number of PV-positive  
(a) and SOM-positive cells (b) in 200 μ m wide cortical columns, lateral (black bars) and medial (grey bars) 
to the ischemic lesion, 7 (PV n = 7; SOM n = 6) and 30 days post injury (PV n = 8; SOM n = 4). Compared 
to controls (PV n = 7; SOM n = 6), density of PV-+ neurons is significantly dampened at 30 days (one Way 
ANOVA, post hoc Holm-Sidak test, p < 0.05). SOM-+ cells are significantly reduced at 7 days and decrease 
further at 30 days. Data are mean ± SE. *p < 0.05; **p < 0.01. (c,d) Representative low magnification images of 
PV (c) and SOM immunostaining (d) in the motor cortex. Images were taken from sham animals and from the 
perilesional areas of mice at 7 and 30 days post-infarct. Column width = 200 μ m.
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major populations of GABAergic cortical interneurons after the infarct. Somatostatin-containing interneurons 
represent a low-threshold inhibitory population involved in cortical plasticity66–68 whereas parvalbumin-positive 
fast-spiking interneurons play important roles in control of network firing due to their perisomatic synapses onto 
pyramidal cells48. It remains to be established whether loss of SOM and PV immunoreactivity is due to cell loss 
or down-regulation of the expression of these markers. However, reduction of GABAergic neurotransmission 
was confirmed by analysis of the number of V-GAT-positive inhibitory presynaptic terminals in the perilesional 
cortex, 30 but not 7 days after stroke. For a reliable quantification of immunofluorescence, we used a reference 
field for each analysed section (see methods) that reduces bias due to different quality of staining in individual 
samples. As compared to other more quantitative methods (such as Western blotting), this analysis has the advan-
tage of ensuring greater spatial selectivity. A reduced inhibitory tone is in keeping with the observation of a loss of 
selectivity in the motor maps, with a dramatic enhancement in the number of sites evoking simultaneous move-
ment of different body parts, and a corresponding reduction in the percentage of cortical area evoking specific 
and unique movements (see Fig. 2a,b).
Overall, our data point to a consistent downregulation of the GABAergic system that is initially detectable 
7 days after stroke and becomes more widespread one month post-stroke, coupled with a reduction of PNNs. 
It has been shown that daily motor rehabilitation in stroke mice triggers an improvement of grasping abilities, 
which is associated with a reduction in parvalbumin, calretinin, and calbindin expression in the agranular cortex 
adjacent to the infarct. These exercise-dependent reductions in inhibition occur in the first week after stroke and 
are not evident without rehabilitation69. Overall, inhibitory networks appear to reorganize extensively in a quite 
large cortical area surrounding the infarct70, which may explain the changes in cortical maps seen by intracortical 
stimulation (present study) and optogenetics11.
It has also been shown that removing PNNs from the perilesional tissue can be beneficial for motor recovery 
after injury22,23. Thus, the release of specific “neuroplasticity brakes” (such as GABAergic neurotransmission and 
PNNs18,45) from the perilesional areas may trigger the reopening of a sensitive period for cortical remodelling 
that allows network reorganization and potentially some restoration of function. This interpretation fits well with 
the finding that, despite a global shrinkage of the affected forelimb representation, specific postero-medial sites 
of the motor cortex appear to gain forelimb responsiveness after stroke (blue “hot spots” in Fig. 2c) indicating a 
Figure 5. Late reduction of V-GAT-positive inhibitory terminals in perilesional cortex. (a,b) Mean 
fluorescence intensity of inhibitory, V-GAT-positive profiles in the neuropil (a) and in puncta rings surrounding 
the soma of pyramidal neurons (b). Measures were taken in superficial (sup) and deep layers, medial and lateral 
to the infarct. A consistent reduction in fluorescence is observed 30 but not 7 days after injury as compared 
to sham controls (one way ANOVA followed by Holm-Sidak test, p < 0.05). Data are mean ± SE. *p < 0.05; 
**p < 0.01. (c) Representative V-GAT immunoreactivity in the motor cortex of sham animals and in perilesional 
tissues (7 and 30 days after the infarct). Note decreased staining at 30 days. Number of animals is as follows: 
control n = 5, stroke 7 days n = 5, stroke 30 days n = 4. Scale bar = 20 μ m.
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Figure 6. Quantitative analysis of V-GluT1 immunostaining. (a,b) Mean fluorescence intensity of excitatory, 
V-GluT1-positive presynaptic structures in the neuropil (a) and in puncta rings surrounding the soma of 
pyramidal neurons (b). Measures were taken in superficial (sup) and deep layers, medial and lateral to the 
infarct. There is no significant variation in staining in stroke animals as compared to sham controls (one Way 
ANOVA, followed by Holm-Sidak test, p > 0.52). Data are mean ± SE. (c) Representative V-GluT1 staining in 
cortical sections from sham controls and stroke mice, 7 and 30 days following injury. Number of animals is as 
follows: control n = 6, stroke 7days n = 6, stroke 30 days n = 5. Scale bar = 20 μ m.
Figure 7. Long-lasting improvements in general motor outcome following DMCM treatment in stroke 
mice. Data are shown as percentage of the initial deficit, i.e. the difference in the fraction of foot faults/
incorrect graspings between day 2 and baseline. Then, performances at day 9 and 30 have been normalized as 
a percentage of the initial deficit. Statistical analysis was performed on raw data and differences refer to day 2. 
(a) The number of foot faults in the gridwalk task decreases immediately after DMCM treatment and persists 
up to 30 days (two way RM ANOVA followed by Tukey test, p < 0.05; n = 10). Conversely, no significant 
improvements are detected in controls (p > 0.87; n = 3). (b) Performance in the single-pellet retrieval task. 
The fraction of incorrect graspings decreases after DMCM treatment, which rescues approximately 70% 
of the initial deficit 30 days post lesion (two way RM ANOVA, followed by Tukey test, p < 0.01). Data are 
mean ± SE.*p < 0.05; **p < 0.01.
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difference between the caudal and rostral regions of the motor cortex in post stroke motor recovery. This finding 
may indicate an initial attempt of the motor network to relocalize lost motor functions. Interestingly, Starkey 
et al.43 observed that in stroke rats with good functional outcome, neurons within the hindlimb motor cortex 
(posterior to the lesion site) acquire the ability of triggering forelimb movements, pointing to compensatory 
take-over by peri-lesional areas.
Several studies have reported a decreased intracortical inhibition in stroke patients71,72. After unilateral stroke, 
Rossini and colleagues found a reduction of intracortical inhibition in the affected hemisphere and normal inhib-
itory levels in the contralesional one73. Kim et al.25 reported reduced GABAA receptor availability in the primary 
motor cortex of stroke patients and these changes in GABA receptor availability were significantly related to 
motor recovery25. In the present experiments, the downregulation of GABA markers at 30 days was accompanied 
by a trend for spontaneous improvement in the skilled reaching test (see in Fig. 7b). Of note, our animals were not 
tested daily, differently from previous reports where major, training-induced improvements in this task have been 
described43,69. Altogether, these data are consistent with the view that a reduction of the inhibitory tone generally 
facilitates the reinstatement of plasticity in the adult cortex49.
Based on these premises, we downregulated GABAergic signalling early after stroke in order to boost such 
spontaneous plastic phenomena. Increasing GABA signalling in post stroke patients and rodent models does not 
improve motor function16. Rather, administering a benzodiazepine after rehabilitation leads to an acute loss of 
the regained function24,74. Finally, lowering tonic GABAergic inhibition improves motor recovery after stroke5,33. 
Here, we targeted GABAergic signalling by using the benzodiazepine inverse agonist DMCM, which reduces 
inhibitory currents by binding predominantly to synaptic GABAA receptor subunits (DMCM binding affinity 
α1 > α 2 = α 3 > α 535). DMCM has been previously used to modulate plasticity in the visual cortex63. Our results 
show a significant improvement in behavioural readouts immediately after the treatment, i.e. day 9 post-stroke, 
which was maintained in the follow-up period up to 30 days after stroke. Improvements were seen both in general 
Figure 8. Kinematic analysis of pellet reaching indicates compensatory adjustments in DMCM-treated 
stroke mice. Data are expressed as percentage of the initial deficit. Post-stroke variation in the length of the 
whole trajectory (ArcLen; a) and in the smoothness of movement (b) during successful pellet retrievals in 
DMCM- (n = 3) and vehicle-treated stroke mice (n = 3). No significant differences are detected between the two 
groups (two way RM ANOVA, p > 0.24).
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motor coordination and in skilled forelimb use, as shown by the gridwalk and pellet grasping task, respectively. 
Improvements were not due to the anxiogenic properties of the drug52, as the motor performance was maintained 
or even enhanced at 30 days after termination of the treatment (see Fig. 7).
We chose to administer DMCM during an early post-stroke phase (day 3 - day 8) corresponding to the period 
of maximal susceptibility to therapeutic interventions75. Reducing GABA neurotransmission too early can have a 
detrimental effect on lesion size and motor outcome5. Indeed, the inhibitory system is believed to dampen excito-
toxic phenomena in the acute phase, thus limiting the extent of damage. On the other hand, previous studies have 
shown that an early therapeutic intervention appears to be critical for the motor outcome41,76. These data suggest 
the existence of a “critical period” during which intervention strategies are more effective. These post-stroke 
events are reminiscent of the sensitive periods in developing sensory cortices, determined by an optimal level 
of GABAA signalling20. In animal models, expression of GABAA receptor subunits shows a complex layer- and 
time-specific regulation after stroke. GABAA receptors generally decrease in perilesional cortical areas5,32,70,77–79. 
Conversely, one recent report80 has shown that α 1 subunit expression is increased in layer 5 after stroke and its 
activation using zolpidem improves recovery. These findings are difficult to reconcile with the present report, 
where the antagonism of the GABA receptors (mainly α 1) appears to promote recovery. The complex post-stroke 
changes in composition and localization of the GABA receptors make it diffcult to clarify the precise site of action 
of the GABA-acting drugs. In particular zolpidem, even if believed to work at the synapse, can act also at the 
extrasynaptic level81, adding complexity to the interpretation of its mechanism of action. In our experiments, 
reducing GABAA signaling via DMCM results in a significant gain of forelimb function after stroke, possibly by 
adjusting the excitation/inhibition balance in specific cortical microcircuits20. Whether DMCM acts at the level 
of the perilesional cortex, contralesional hemisphere or subcortical structures remains to be addressed. Overall, 
downregulation of GABAA signalling during an early post-stroke period appears to leave a persistent trace on 
post-stroke networks that translate into a long-lasting motor improvement.
Altogether, our data highlight a coordinated remodelling of GABAergic inhibitory networks that play an 
important role in post-stroke behavioural gains. Pharmacological therapies impacting on GABAergic signalling 
may accelerate and improve such spontaneous plastic adjustments resulting in significant, even if not complete, 
restoration of motor function. In fact, DMCM treatment was effective to improve general motor and skilled task 
but not the kinematics of reaching movements, possibly because of the lack of a specific rehabilitation that guides 
the re-establishment or pre-lesion motor patterns. It is possible that an appropriate combination of reduced 
GABAergic signalling and motor training leads to synergic effects resulting in a more complete post-stroke motor 
recovery2. In keeping with this idea recent studies have reported an additive or synergic effect of motor rehabil-
itation with plasticizing treatments, e.g. treatment with chondroitinase ABC was potentiated by task specific 
rehabilitation in spinalized rats82. In this context we recently introduced a robotic platform that allows animals 
to perform repeated controlled sessions of forelimb retraction and represents a promising tool for intensive and 
specific forepaw motor training83.
Materials and Methods
Experimental design. All procedures were performed in accordance with the EU Council Directive 
2010/63/EU on the protection of animals used for scientific purposes, and were approved by the Italian Ministry 
of Health. A total of 60 C57BL6J mice were used (22–27 g, age 8–10 weeks).
As shown in Supplementary Fig. S5, a subset of these animals was used to assess behavioural, functional and 
histological changes after focal cortical stroke in CFA (n = 18), compared with control animals (n = 23). In order 
to investigate the time-course of functional motor deficits along the post-stroke acute-phase (i.e. up to 30 days 
after infarct), a baseline session for general motor tests (gridwalk and Schallert cylinder tests) was acquired before 
the photothrombotic (n = 11) or sham (n = 9) procedure and mice were retested in motor tests on days 2, 9, 16, 
23, and 30 post lesion. In order to examine plasticity markers, a subgroup of stroke (n = 8) and sham (n = 8) 
animals underwent paraformaldehyde fixation at the end of the behavioural evaluation period (i.e. at 30 days 
post-stroke). Additional 6 stroke animals were examined at 7 days post-lesion. Moreover, we evaluated functional 
remapping of forelimb representation through Intracortical microstimulation (ICMS) experiments 30 days after 
injury in a total of 6 photothrombotic animals, compared with 9 control mice.
Based on the data obtained in the first part of this study (see Results), we planned a second experiment to eval-
uate if reductions in GABAergic signalling were causally involved in motor improvements. In order to establish a 
suitable dose of DMCM we performed the open field test in DMCM (n = 3) or vehicle (n = 3) mice.
To assess the impact of DMCM on post-stroke recovery, a second pool of 13 animals was tested in the grid-
walk and Schallert cylinder tests to establish a pre-injury baseline performance. Among them, 6 mice had been 
also trained for two weeks in a custom-made skilled reaching apparatus39 until the performance showed a plateau, 
to collect at least three baseline sessions. All animals underwent cortical stroke and then were randomly assigned 
to the DMCM group (n = 10, 3 of which performed also the skilled reaching test) or vehicle group, i.e. saline 
solution, (n = 3). DMCM/vehicle was delivered from day 3 to day 8 post-lesion and motor tests were performed 
on days 2, 9 and 30.
Photothrombotic lesion. The photothrombotic lesion was induced as previously described39. Briefly, after 
a midline scalp incision, Rose Bengal (0.2 ml of a 10 mg/ml solution in PBS; Sigma Aldrich) was injected intra-
peritoneally and the brain was illuminated through the intact skull for 15 min using a cold light source (ZEISS 
CL 6000) positioned 0.5 mm anterior and 1.75 mm lateral from Bregma (i.e. in correspondence with the caudal 
forelimb area; Tennant et al.44; Vallone et al.84). (see supplementary information).
Motor tests. Gridwalk Test. Animals were allowed to walk freely for 5 minutes on an elevated grid 
(32 × 20 cm, with 11 × 11 mm-large openings) and the task was video-recorded. The video recordings were 
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analyzed off-line by means of a custom-designed Graphical User Interface implemented in Matlab39, to assess cor-
rect steps and foot-faults, i.e. steps not providing body support, with the foot falling into grid hole. The percentage 
of foot faults for each limb was then calculated, as previously described39 by a blinded experimenter.
Schallert Cylinder Test. Animals were placed in a Plexiglas cylinder (8 cm diameter, 15 cm height) and recorded 
for 5 minutes by a video-camera placed below the cylinder. Videos were analyzed frame by frame and the spon-
taneous use of both forelimbs was assessed during exploration of the walls, by counting the number of contacts 
performed by the paws of the animal. The experimenter was blinded to the experimental group. For each wall 
exploration, the last paw that left and the first paw that contacted the wall or the ground were assessed. In order 
to quantify forelimb-use asymmetry displayed by the animal, an Asymmetry Index was computed, according to 
Lai et al.39.
Skilled Reaching Test and Kinematic Analysis. The percentage of correct movements and the kinematic analysis 
of the whole reaching movements were performed as previously described39. Briefly, animals (food deprived for 
15 hours) were placed in a testing chamber with transparent walls and trained to perform a skilled reaching task 
with their preferred paw, which had to pass through a small frontal rectangular aperture (0.5 × 1.3 cm) to grasp 
and retrieve food pellets. The task was recorded by a high frame-rate video camera (Hero 3, GO-Pro, USA), 
placed on the side of the testing chamber thus allowing for a sagittal view of the animal. The shaping phase 
consisted in 2 days of habituation, in which a few pellets were placed inside the chamber. During the next phase, 
animals were trained daily until they reached 30 pellets in a single session (each lasting maximum 20 minutes). 
Animals were trained for a couple of weeks until they reached a plateau in the performance. The baseline value 
was obtained using the average of the last 3 sessions prior to the stroke. After the ischemic lesion animals were 
tested once a week without any additional training sessions.
The number of correct (i.e., a reach and grasp movements ending with pellet eating) and incorrect movements 
(i.e., when the mouse passed by the frontal window and reached the pellet but missed it or dropped the pellet 
after grasping it) were manually assessed. Then the percentage of incorrect grasping was calculated over the total 
attempts (i.e. total number of times that the paw crossed the frontal window.
Off-line reconstruction of paw trajectories was performed by a semi-automated algorithm based on colour 
contrast analysis, as described in Lai et al.39. Briefly, the algorithm tracked the trajectories of the preferred paw 
on the sagittal (x, y) plane by identifying the position of the paw previously painted with a green non-toxic 
dye (Stabilo Boss, Stabilo, Germany). To ensure consistency, only trajectories from successful trials (i.e. correct 
movements) were considered. Changes in the trajectories were quantified by the length of the whole trajectory 
(ArcLen) and the number of peaks in the tangential velocity profile (Smoothness). A detailed description of kin-
ematic parameters is provided in Lai et al.39.
Open field test. Thirty minutes after DMCM treatment, animal were placed in a Plexiglass 60 cm × 60 cm arena 
with a white background and black walls for 10 minutes. The position of the animal during the test was automat-
ically tracked using EthoVision XT (Noldus, Netherlands) and the total distance travelled was computed at the 
end of each experimental session.
Intracortical Microstimulation (ICMS). Animals were anesthetized using a ketamine (100 mg/kg) and 
xylazine (10 mg/kg) cocktail. The cortex was stimulated through a tungsten microelectrode (1 MΩ, FHC, USA), 
following a grid with nodes spaced 250 μ m. At each penetration site, a 40 ms train of 13 cathodic current pulses 
(0.2 ms duty cycle) was delivered at 350 Hz from an electrically isolated, constant current stimulator (World 
Precision Instruments Inc., USA). The amplitude of the pulses was increased from a minimum of 20 μ A to a max-
imum of 60 μ A (with steps of 10 μ A). Movements of several body parts were collected by a second experimenter, 
blinded to the stimulation coordinates in the grid.
Data Analysis. Data collected during ICMS were analyzed through a custom made algorithm developed in 
Matlab (Mathworks, USA) in order to obtain body part maps, multiple-site analysis and Transition Index (see 
supplementary information).
Immunohistochemical analysis. At the end of the experiment, all animals were transcardially per-
fused with 4% paraformaldehyde. Brains were cut using a sliding microtome (Leica, Germany) to obtain 50-μ m 
thick coronal sections that were used for immunostaining (see supplementary information). The number of 
Perineuronal Nets, Parvalbumin- and Somatostatin-positive neurons was analysed using a fluorescence micro-
scope (Zeiss, Germany) with a 10x objective, counting in a 200 μ m wide cortical column drawn at the medial and 
lateral edge of the ischemic tissue (Fig. 5) by Stereo Investigator software (MBF Bioscience, USA). Three sections 
per animal were analysed. The V-GAT e V-GluT1 signals were acquired using a confocal microscope (Leica, 
Germany) with a 63x objective and a 2.5 digital zoom, in medial-superficial/deep and lateral-superficial/deep 
regions in the perilesional tissue (Fig. 5). Three fields (95 μ m × 95 μ m) for each location were acquired (three 
sections per animal). Acquired images were processed using Metamorph software (Molecular devices, USA)
to analyze the mean fluorescence in the entire image and in puncta rings regions by an experimenter blinded to 
the group18,85,86. To minimize variations due to the different quality of the immunostaining in individual mice/
sections, fluorescence in perilesional areas was normalized to values calculated in three reference fields taken in 
the basal cortices of each analyzed coronal section.
To quantify the lesion volume, 1 out of every 6 sections was stained with Hoechst 33258 (Sigma-Aldrich, 
USA). The ischemic region was contoured using a 10x objective and its area measured. The lesion volume for each 
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animal was calculated by summing up all damage areas and multiplying the number by section thickness and 
by 6 (the spacing factor). A total infarction volume in mm3 is given as the mean ± standard error of all analyzed 
animals.
DMCM treatment. DMCM (methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate) (Tocris, United 
Kingdom) was reconstituted in sterile water to obtain a concentration of 4 mg/ml. The DMCM treatment started 
at day 3 post lesion and continued up to day 8. DMCM (1.5 mg/kg) was delivered intraperitoneally under brief 
isoflurane anaesthesia twice a day, 10 hours apart. Behavioural effects of this dose of DMCM were verified in naïve 
mice by quantifying total distance travelled in the open field.
Statistical Analysis. All statistical tests were performed using SigmaPlot 11.0 (Systat Software Inc, USA). 
For behavioural tests (gridwalk test, Schallert cylinder test, open field and skilled reaching test) a Two Way 
Repeated Measures ANOVA was used followed by a Tukey’s Test. For Immunohistochemical analysis One Way 
ANOVA was used followed by a Holm-Sidak test, or ANOVA on ranks followed by Dunn’s test when the sample 
failed the normality test. For intracortical microstimulation data a T-test was used. All statistical analyses were 
performed on raw data (alpha value 0.05).
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